Últimas noticias sobre Lufax Holding (NYSE:LU) Bolsa

Lufax Holding

Lufax Holding Ltd is a technology-empowered personal financial services platform in China. The company address the large unmet demand for personal lending among small business owners as well as salaried workers in China and provides tailor-made wealth management solutions to China's middle class and affluent population. Its platform has two hubs namely Retail Credit Facilitation Hub and Wealth Management Hub.

Lufax Holding Ltd American Depositary Shares, each representing two (2) Ordinary Shares

Lufax Holding Ltd

LuaSwap

LUCA INC by Luca, Inc.

Lucid Diagnostics Inc

Lucky Strike Entertainment Corporation Class A Common Stock

Lucky Strike Entertainment Corp

LUCKY CEMENT LTD GDR 144A by Lucky Cement Ltd.

Lucky Cement Ltd

Luca Mining Corp

Lucent Inc

LUCARA DIAMOND CORP by Lucara Diamond Corp.

Lucara Diamond Corp

Innovative Eyewear Inc

Luda Technology Group Limited Ordinary Shares

Luda Technology Group Ltd

LUDWIG ENTERPRISES by Ludwig Enterprises, Inc.

Ludwig Enterprises Inc

Leeds United Fan Token

Herbal Dispatch Inc

HERBAL DISPATCH INC by HERBAL DISPATCH INC.

Lundin Gold Inc

REAL LUCK GROUP LTD by Real Luck Group, Ltd.

Real Luck Group Ltd

PJSC LUKOIL S/ADR 144A by PJSC Lukoil

PJSC LUKOIL S/ADR by PJSC Lukoil

Lululemon Athletica Inc

LUMBEE GUARANTY BK by Lumbee Guaranty Bank

Lumbee Guaranty Bank

Luminex Resources Corp

Lumen Technologies Inc

LUMOS PHARMA INC COM

LUNA INNOVATIONS INC by Luna Innovations, Inc.

Luna Innovations Inc

Terra - United States Dollar

Luna 2.0 - United States Dollar

Terra Classic - United States Dollar

Pulmonx Corp

LUNDIN MINING CORP by Lundin Mining Corp.

Lundin Mining Corp

Intuitive Machines, Inc. - Class A Common Stock

Intuitive Machines Inc

Intuitive Machines Inc Warrants (13/02/2028)

LUOYANG GLASS CO LTD H by LUOYANG GLASS COMPANY LTD.

Triumph New Energy Co Ltd

LoopUp Group PLC

Labrador Uranium Inc

Liquity USD

Southwest Airlines Co

LITHIUM UNIVERSE LTD by Lithium Universe Limited

Lithium Universe Ltd

Luvu Brands Inc

Tema ETF Trust Tema Luxury ETF

LUXXFOLIO HLDGS INC NEW by LUXXFOLIO HLDGS INC

Luxxfolio Holdings Inc

LUXURBAN HOTELS INC by LuxUrban Hotels Inc.

LuxUrban Hotels Inc

LUXURBAN HOTELS INC A PFD by LuxUrban Hotels Inc.

Listed Funds Trust Roundhill S&P Global Luxury ETF

Morgan Stanley analyst Brian Nowak maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Overweight and lowers the price target from $210 to $185.

News

Price Target

Analyst Ratings

GOOGL

Morgan Stanley Maintains Overweight on Alphabet, Lowers Price Target to $185

Morgan Stanley analyst Brian Nowak maintains Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) with a Underweight and raises the price target from $125 to $130.

ABNB

Morgan Stanley Maintains Underweight on Airbnb, Raises Price Target to $130

Guggenheim analyst Vamil Divan reiterates Merck &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) with a Buy and maintains $115 price target.

Reiteration

Guggenheim Reiterates Buy on Merck & Co, Maintains $115 Price Target

Morgan Stanley analyst David Lewis maintains Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) with a Equal-Weight and raises the price target from $117 to $127.

Morgan Stanley Maintains Equal-Weight on Abbott Laboratories, Raises Price Target to $127

WIIM

CHRO

Channel Therapeutics shares are trading higher after the company announced that it will combine with Ligand Subsidiary Pelthos Therapeutics to create a pain medicines focused entity.

Maxim Group analyst Tate Sullivan initiates coverage on Heidmar Maritime Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HMR#NASDAQ">HMR</a>) with a Buy rating and announces Price Target of $7.

Initiation

Maxim Group Initiates Coverage On Heidmar Maritime Holdings with Buy Rating, Announces Price Target of $7

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) investors are facing unprecedented pressure as Glassnode data shows the <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44789931/strategy-adds-3459-bitcoin-despite-q1-losses-holds-25-of-btc-supply">largest unrealized losses</a> on record, concentrated among new market participants.
Despite Bitcoin's relative price resilience, capital inflows have slowed, and liquidity continues to tighten across the digital asset landscape.
What Happened: The <a href="https://insights.glassnode.com/the-week-onchain-week-15-2025/">analysis</a> attributes this strain to the convergence of global macroeconomic volatility, liquidity contraction and subdued capital inflows, all of which have intensified stress across the crypto market.
While veteran holders, or &#8220;long-term holders,&#8221; remain broadly in profit, the bulk of current unrealized losses is concentrated among newer participants who bought during recent highs.
The macroeconomic backdrop is compounding investor strain. 
<a href="https://www.benzinga.com/markets/25/04/44831287/trump-administration-imposes-up-to-245-tariff-on-chinese-imports-amid-intensifying-trade-battle">Heightened geopolitical uncertainty</a> and <a href="https://www.benzinga.com/news/global/25/04/44860334/china-cuts-us-oil-purchases-by-90-boosts-imports-from-canada-to-new-heights">tariff-driven trade realignment</a> under the Trump administration have pushed U.S. Treasury yields higher again, with the 10-year yield surging back to 4.5% after a brief dip earlier this year.
Glassnode notes this is creating extreme bond market volatility, as reflected in the elevated MOVE Index, a key gauge of Treasury market stress.
This instability has trickled into digital assets. 
Bitcoin fell as low as $75,000 during the recent market shock before rebounding to around $85,000. 
Still, the drawdown marks Bitcoin's largest correction in the 2023–25 cycle, pulling back 33% from its all-time high. 
Yet, that drop remains relatively moderate compared to past cycles, where similar conditions triggered 50%+ declines.
"Drawdowns since 2023 have been shallower and more controlled," Glassnode reported. 
This indicates growing investor maturity and resilience — particularly among long-term holders, who have largely remained unfazed.
Despite the psychological toll of losses, 75% of Bitcoin's circulating supply remains in profit. 
However, the proportion of coins in loss, totaling $410 billion in realized cap terms, is the highest in history. 
According to Glassnode, this figure exceeds the losses seen during the 2021 crash and the depths of the 2022 bear market.
As newer investors age into long-term holder status, the risk of structural drawdown intensifying grows. 
Glassnode warns that if these positions remain underwater, historical patterns suggest the market could slide further toward a full-fledged bear regime.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44861571/donald-trump-blasts-too-late-and-wrong-fed-chair-powell-but-polymarket-traders-doubt-his-termination-will-come-fast-enough">Donald Trump Blasts &#8216;Too Late And Wrong&#8217; Fed Chair Powell, But Polymarket Traders Doubt His &#8216;Termination&#8217; Will Come &#8216;Fast Enough&#8217;</a>
Why It Matters: Meanwhile, stablecoin growth has stalled, and capital inflows have dropped to just +0.9% monthly — further evidence of risk-off sentiment.
"Realized cap is at an ATH of $872 billion, but the pace of growth has slowed substantially," Glassnode notes, signaling market hesitation.
For now, the market sits at a pivotal juncture. 
Metrics like Net Realized Profit/Loss have reset to long-term medians, often indicative of decision points between continued consolidation or a breakout trend.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44860392/ex-sec-chair-gary-gensler-says-bitcoin-driven-by-sentiment-not-fundamentals">Ex-SEC Chair Gary Gensler Says Bitcoin Driven By Sentiment, Not Fundamentals</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Unrealized Bitcoin Losses Hit All-Time High, Glassnode Says: Bear Market Signs?

Interactive Brokers Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) reported its first-quarter results on Wednesday, with <a href="https://www.benzinga.com/trading-ideas/movers/25/04/44852229/interactive-brokers-misses-q1-earnings-analyst-flags-weaker-securities-lending-revenue">downbeat sales and earnings</a>.
Despite market selloffs, customers may not have stopped trading and the company's "secular account growth continues (and could even improve)," according to Goldman Sachs.&nbsp;
The Interactive Brokers Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6149a1cd46584a00014583f4/james-yaro">Analyst James Yaro</a> maintained a Buy rating, while reducing the price target from $222 to $219.
The Interactive Brokers Thesis: The company's net revenue missed consensus by 1%, partially offset by pre-tax margins that were 10 basis points higher, leading to adjusted earnings of $1.88 per share falling short of consensus of $1.91 per share, Yaro said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Interactive Brokers' net interest income missed consensus by 5%, "as a result of a greater portion of customer balances in jurisdictions that have seen rapid rate cuts than we/consensus had contemplated," he added.
The company indicated that account growth is likely to have accelerated so far in April, despite the broader market selloff, the analyst stated.
"We believe that this should reassure investors that customers are not disengaging from trading so far, as in previous market sell-off episodes, and the company's secular account growth continues (and could even improve)," he further wrote.
Interactive Brokers has plans to launch new products to more markets through 2025, Yaro said.
IBKR Price Action: Shares of Interactive Brokers had risen by 0.01% to $157.91 at the time of publication on Thursday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44634737/retailers-brace-for-higher-costs-as-us-tariff-rates-soar-says-goldman-sachs">These Analysts Revise Their Forecasts On Interactive Brokers Following Q1 Results</a></li>
</ul>
Image: Shutterstock

Analyst Color

IBKR

Interactive Brokers Disappoints In Q1, Analysts Praise Account Growth Despite Stock Market Bloodbath

Faraday Future Intelligent Electric Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFAI#NASDAQ">FFAI</a>) shares are trading higher. The company on Thursday announced plans to maintain its Nasdaq listing without enacting a <a href="https://www.benzinga.com/pressreleases/25/04/b44858829/faraday-future-announces-that-it-resolutely-opposes-a-reverse-stock-split-is-committed-to-maintain">reverse stock split</a>.
What To Know: After falling below the $1 minimum bid price listing requirement on Wednesday, Faraday Future announced a five-point action plan to maintain its listing status. 
The company said it will continue to optimize its capital structure with a commitment to avoid a reverse stock split through the strategic deployment of equity and convertible debt offering proceeds to help support business development.
Faraday Future also said it plans to initiate a new round of executive share purchases with broad participation across the leadership team to help instill investor confidence.
The company acknowledged that <a href="https://www.benzinga.com/topic/tariffs">recent tariffs</a> could impact the company&#8217;s FX strategy in the near term, but Faraday Future sees it as an opportunity over the longer term. The company noted that it&#8217;s actively engaging with the U.S. government and has submitted constructive proposals regarding automotive policy.
Faraday said it plans to accelerate its FX vehicle program in an effort to roll out the first vehicle by the end of the year, increase transparency and engagement with shareholders and initiate a governance transformation. 
The transformation will be focused on eliminating inefficiencies and unleashing full operational potential. The company said it will host an Investor Community and Co-Creation Day on April 24 to engage shareholders in open, face-to-face dialogue.
See Also: <a href="https://www.benzinga.com/markets/equities/25/04/44862552/ford-recalls-nearly-150000-vehicles-over-brake-and-powertrain-issues-nhtsa">Ford Recalls Nearly 150,000 Vehicles Over Brake And Powertrain Issues: NHTSA</a>
<h3 class="wp-block-heading">How To BUY FFAI Stock</h3>
By now you're likely curious about how to participate in the market for Faraday Future &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
FFAI Price Action: Faraday Future shares were up 4.82% at $0.91 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: courtesy of Faraday Future.

Movers

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

What's Going On With Faraday Future Stock Thursday?

Guggenheim analyst Vamil Divan reiterates AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) with a Buy and maintains $214 price target.

ABBV

Guggenheim Reiterates Buy on AbbVie, Maintains $214 Price Target

Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) has outperformed the market over the past 10 years by 1.4% on an annualized basis producing an average annual return of 11.03%. Currently, Globus Medical has a market capitalization of $9.94 billion. 
Buying $1000 In GMED: If an investor had bought $1000 of GMED stock 10 years ago, it would be worth $2,828.51 today based on a price of $72.30 for GMED at the time of writing.
<h3>Globus Medical's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744903831_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

GMED

Here's How Much You Would Have Made Owning Globus Medical Stock In The Last 10 Years

IPOs

Chagee IPO Price Indicating $33.60/ADS; IPO Priced At $28/ADS On 14.68M Shares

The <a href="https://www.benzinga.com/topic/artificial-intelligence">AI-fueled rally</a> in semiconductors just ran into a geopolitical buzzsaw. NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) disclosed this week that the U.S. government has imposed new license requirements for selling their AI-focused chips — Nvidia&#8217;s H20 and AMD's MI308 — to China, Hong Kong, Macau and several D:5 countries.
Nvidia responded with a $5.5 billion inventory charge, effectively bracing for a complete block in shipments. AMD booked an $800 million hit of its own. JPMorgan analyst Harlan Sur estimates that these curbs will shave off 8%-10% of both companies&#8217; earnings this year.
Read Also: <a href="https://www.benzinga.com/markets/25/04/44858727/jensen-huang-in-china-for-talks-as-us-tightens-nvidia-chip-restrictions-report">Jensen Huang In China For Talks As US Tightens Nvidia Chip Restrictions: Report</a>
<h1 class="wp-block-heading">The China Revenue Stream? Drying Up Fast</h1>
Nvidia's China data center business previously contributed a low-teens percentage to its overall data center revenue. With H20 shipments now in limbo, Sur expects that number to fall to "a de minimis level."
AMD, meanwhile, faces an estimated $1.5–$1.8 billion revenue impact on the back of the $800 million inventory charge. That's roughly 10% of its expected data center sales this year, noted Sur. The fallout isn't confined to the second quarter &#8211; the guidance hit spans all of 2025.
<h1 class="wp-block-heading">Winners, Losers — And The Silicon Side Effects</h1>
Sur believes there's still heavy AI demand in China — but now Chinese firms may accelerate a pivot to domestic alternatives like Huawei's Ascend chips or custom ASICs. In a surprising silver lining, custom AI ASIC projects remain unaffected by the new rules.
That's good news for players like Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), which continues to ramp up shipments for its third major custom AI customer. As it stands, merchant solutions like Nvidia and AMD's GPUs are feeling the heat, while bespoke chips enjoy relative regulatory immunity — for now.
With new AI diffusion rules starting mid-May and a looming Section 232 probe on imported chips, this may be just the opening chapter of a longer regulatory saga for U.S. semiconductor giants.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44861917/broadcom-marvell-synopsys-the-chips-that-might-not-crumble-in-the-coming-storm">Broadcom, Marvell, Synopsys: The Chips That Might Not Crumble In The Coming Storm</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Global

Tech

AVGO

NVDA

Nvidia, AMD Take A $17 Billion Hit In The AI Arms Race, While Broadcom Remains Shielded, Says Analyst

ADGM

Adagio Medical Shares Resume Trade

JNVR

Janover Shares Resume Trade

Guggenheim analyst Joseph Osha reiterates Itron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRI#NASDAQ">ITRI</a>) with a Buy and maintains $133 price target.

ITRI

Guggenheim Reiterates Buy on Itron, Maintains $133 Price Target

Editor&rsquo;s note: This article was originally published in May 2024. Some time references have been adjusted for clarity.
&ldquo;Endometriosis made me want to jump off a building,&rdquo; <a href="https://elplanteo.com/tiffany-haddish-marihuana-salud-berner/">Tiffany Haddish</a> admits candidly, revealing the extent of her chronic pain. For Haddish, <a href="https://www.benzinga.com/cannabis">cannabis</a> has been a vital tool for coping with the relentless agony she faces during her menstrual cycle. Her voice carries real gravitas as she describes how smoking marijuana helps relieve the physical pain she has suffered for years. &ldquo;When I discovered the actual power of marijuana and how it can help relieve that inflammation, bring that pain down&hellip; It has helped me so much,&rdquo; she explains. &ldquo;I went to Panama and learned about the different things that cannabis can do and how you can use it. I like mixing it [cannabis leaves] with coconut water and making tea out of the flower.&rdquo;
Haddish isn&#39;t a stranger to cannabis. She first tried it at 18 but found herself overwhelmed with laughter and discomfort. &ldquo;I didn&#39;t like that. I couldn&#39;t stop laughing. So I was like, &lsquo;I&#39;m not messing with this,&rsquo;&rdquo; she voices.
She returned to the herb later, in her early twenties, while navigating emotional turmoil. &ldquo;I had a choice between some weed and some other drug. And I chose the weed because I felt like that was a card, versus the other thing that was sitting on the table there,&rdquo; she says. From that moment on, marijuana has played a significant role in her life, evolving from an occasional escape to a reliable source of relief during her most painful times. &ldquo;It made me feel relaxed. It took away a lot of my emotional pain. At first, it was like an occasional thing. Then, as I experienced endometriosis pain, especially during my cycles, during my period, I would smoke weed basically for a week straight while I was bleeding. And that changed the game for me. I was able to function. I wasn&#39;t like crying and super emotional all the time,&rdquo; she adds.
The comedian has long been outspoken about the ways in which cannabis has positively impacted her life. She&rsquo;s not shy about the medical benefits, recounting how cannabis has helped her manage pain and improve her overall well-being.
<h3>Cannabis And Endometriosis</h3>
The use of cannabis to manage endometriosis has garnered interest in recent years, with research offering promising insights into its efficacy. A study published in the&nbsp;<a href="https://www.sciencedirect.com/science/article/abs/pii/S1701216319308084" rel="nofollow noopener noreferrer" target="_blank" title="https://www.sciencedirect.com/science/article/abs/pii/S1701216319308084">Journal of Obstetrics and Gynaecology Canada</a>&nbsp;surveyed Australian women with surgically confirmed endometriosis, revealing that 13% of them turned to cannabis as a self-management strategy for symptom relief. The study showed that cannabis was particularly effective in reducing pain, with a self-reported effectiveness score of 7.6 out of 10, and 56% of women who used cannabis were able to reduce their reliance on pharmaceutical medications by at least half. Participants also reported improvements in sleep, nausea and vomiting, with few adverse effects observed.
Studies published through 2023 have further investigated the potential of cannabis in treating endometriosis-related pain and its associated symptoms. A review published in the&nbsp;<a href="https://www.news-medical.net/news/20231114/Cannabis-shows-promise-in-easing-endometriosis-pain-new-research-suggests.aspx" rel="nofollow noopener noreferrer" target="_blank" title="https://www.news-medical.net/news/20231114/Cannabis-shows-promise-in-easing-endometriosis-pain-new-research-suggests.aspx">Journal of Clinical Medicine</a>&nbsp;analyzed existing research on cannabis use for endometriosis, uncovering promising mechanisms where cannabinoids interact with the endocannabinoid system (ECS) and the gut microbiome to alleviate symptoms. The review highlighted that cannabis-derived compounds can have anti-inflammatory effects, decrease gut permeability, and act as natural painkillers, offering significant relief from bloating, a common endometriosis symptom. Another study published in&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547625/" rel="nofollow noopener noreferrer" target="_blank" title="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547625/">PLOS One</a>&nbsp;collected data from over 250 participants with self-reported endometriosis, recording more than 16,000 cannabis use sessions. The results indicated that cannabis effectively reduced pelvic pain and improved gastrointestinal symptoms and mood, with inhaled cannabis showing quick pain relief, while oral ingestion had a longer-lasting effect for mood-related symptoms.
In Haddish&rsquo;s view, many women are suffering silently due to a lack of understanding and awareness about conditions like hers. Cannabis, for her, offers a viable solution. &ldquo;I think it&#39;s not talked about widely because men don&#39;t get endometriosis. If men got endometriosis, it would probably be something talked about&hellip; You need to give women the right to be able to smoke or ingest cannabis legally&hellip; If you are going to take the right for women to make the decisions off of their uterus, then you need to give them the right to be able to smoke or ingest cannabis legally, completely across the board,&rdquo; she says.
<h3>Acting Through The Pain</h3>
&ldquo;That&#39;s why I think I&#39;m a phenomenal actress; I learned how to act through the pain, but I&#39;m dying on the second day [of my cycle],&rdquo; Haddish asserts, emphasizing the toll endometriosis took on her daily life. Smoking marijuana made it possible for her to function during those difficult times. Over the years, she became more conscious of the ways cannabis could enhance her health.
For Haddish, cannabis is also key in managing other health issues. She shares stories of friends who have multiple sclerosis. Initially, they were against marijuana, she says, but medical advice convinced them to try it. They quickly experienced improved mobility and communication. This is why Haddish highlights how cannabis can help those with health challenges in moderation and when used with purpose.
&ldquo;I&#39;ve never hid my cannabis use from anybody &ndash; except for maybe my grandma. And then I did a TV show way back in 2008. And, I know she knew, cause she could see the roaches in the ashtray, but that I would try to hide under the bed and stuff when she would come to my house,&rdquo; Haddish says with a chuckle.
Despite her love for cannabis, Haddish has had to change how she consumes it. As of mid-2024, she had stopped using THC due to testing requirements but remains unperturbed. &ldquo;I haven&#39;t experienced any withdrawal symptoms,&rdquo; she notes, adding that she&#39;s still able to enjoy the other benefits of cannabis through non-THC products like teas and other extracts.
<h3>A Freaky Collaboration</h3>
Cookies, the influential cannabis brand co-founded by rapper and entrepreneur&nbsp;<a href="https://elplanteo.com/berner-enamoro-cannabis-musica/" target="_self" title="https://www.forbes.com/sites/javierhasse/2020/09/16/berner/?sh=469493b9541d">Berner</a>, teamed up with TV show &ldquo;The Freak Brothers&rdquo; in 2024 for a unique collaboration that merged cannabis culture with entertainment. For Berner, stepping into the world of &ldquo;The Freak Brothers&rdquo; felt surreal. &ldquo;It&rsquo;s a real trip to see myself in the Freaksverse alongside entertainers I&rsquo;ve looked up to for a while,&rdquo; he remarked, appreciating the chance to blend his passion for cannabis with a project that has such deep roots in counterculture.
<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" frameborder="0" height="315" src="https://www.youtube.com/embed/91Gp4tKYktU?si=acfqEqrzGjjLS6iG" width="560"></iframe>
The original &ldquo;The Freak Brothers&rdquo; comic series, created by Gilbert Shelton in the late 1960s, carries a legacy that continues to shape cannabis culture today. Known for its counterculture humor and satirical take on stoner life, the comic found a new home as an adult animated series, featuring a cast that includes Haddish,&nbsp;<a href="https://www.forbes.com/sites/lindseybartlett/2022/05/16/woody-harrelson-talks-cannabis-at-the-woods-dispensary-opening/?sh=273571555c45" target="_self" title="https://www.forbes.com/sites/lindseybartlett/2022/05/16/woody-harrelson-talks-cannabis-at-the-woods-dispensary-opening/?sh=273571555c45">Woody Harrelson</a>, John Goodman, Pete Davidson and Berner. This modern incarnation pays homage to the series&#39; roots while bringing it into the contemporary world of cannabis and entertainment.
<img alt="Cookies x 'The Freak Brothers'" src="https://imageio.forbes.com/specials-images/imageserve/66327a9fcd7689830eb246af/Cookies-x--The-Freak-Brothers-/960x0.jpg?format=jpg&amp;width=1440" style="height:450px; width:360px" />
Cookies x &#39;The Freak Brothers&#39;. COURTESY OF COOKIES
In tandem with the TV show, Cookies and &ldquo;The Freak Brothers&rdquo; released a special joint, aptly named the &ldquo;LSD Joint.&rdquo; The collaboration behind this product reflected the shared ethos of both brands. As Berner explained, &ldquo;The synergy was undeniable &mdash; kind of like an old school meets new school vibe with us both being from The Bay.&rdquo; The limited-edition product aimed to create something the original Freaks themselves would&rsquo;ve enjoyed in the &#39;60s and &#39;70s &mdash; and quickly became a fan favorite before selling out.
&ldquo;With the Freaks being a real trippy crew, we just knew we needed to put something out that the Freaks themselves would have loved to spark up back in the 60s and 70s,&rdquo; the rapper added.
Although the Cookies x Freak Brothers collab is no longer available, it remains a vivid illustration of how far cannabis culture has come. It stands as a testament to the evolving perception of cannabis in popular media, where the lines between entertainment and advocacy are increasingly blurred.
Berner was enthusiastic about the cultural shift that allowed a stoner show like &ldquo;The Freak Brothers&rdquo; to reach the mainstream. &ldquo;Man, I love to see more mainstream entertainment embracing the culture, it&rsquo;s about time,&rdquo; he said.
<h3>&lsquo;If You&rsquo;re Lazy, You&rsquo;re Lazy&rsquo;</h3>
Navigating the shifting terrain of cannabis acceptance, Haddish embodies a spirit of authenticity and openness that resonates deeply within the community. She&rsquo;s quick to counter negative stereotypes around cannabis users, especially those who assume it leads to laziness or a lack of productivity. &ldquo;If you&rsquo;re lazy, you&rsquo;re lazy. Period,&rdquo; she asserts, noting how cannabis can be an integral part of a balanced, healthy lifestyle.
&ldquo;There are lots of very productive, business-minded, business-oriented, resolute people that smoke or ingest marijuana in some sort of way, shape or form,&rdquo; she adds, emphasizing how many successful individuals incorporate cannabis into their lives without compromising their productivity.
Haddish doesn&#39;t hesitate to highlight the contrasting effects of alcohol and cannabis, suggesting that alcohol should be illegal due to its negative impacts on society. &ldquo;There&rsquo;s a lot of domestic violence because of alcohol. A lot of child abuse because of alcohol, but not because of weed,&quot; she points out. For Haddish, cannabis promotes relaxation and calm, in stark contrast to the aggression often linked to alcohol consumption.
By means of conclusion, the actress emphasizes the importance of intent in usage, urging people to understand their purpose for consuming cannabis and to align it with their goals, whether for sleep, pain management, or&nbsp;<a href="https://www.forbes.com/health/mind/what-is-anxiety/" target="_self">anxiety</a>&nbsp;relief. She strongly believes in legalization, particularly for women. In her view, there are many misconceptions about cannabis, and &ldquo;a lot of women are in jail right now, because of endometriosis, because it will make you make some poor decisions.&rdquo;
&ldquo;But I&#39;ve never seen nobody try to hurt anybody or fight anybody after taking in a little bit of marijuana,&rdquo; she ends.
Follow me on&nbsp;<a href="https://www.twitter.com/javierhasse" rel="nofollow noopener noreferrer" target="_blank">Twitter</a>&nbsp;or&nbsp;<a href="https://www.linkedin.com/in/javierhasse/" rel="nofollow noopener noreferrer" target="_blank">LinkedIn</a>.&nbsp;Check out&nbsp;my&nbsp;<a href="https://elplanteo.com/" rel="nofollow noopener noreferrer" target="_blank">website</a>&nbsp;or&nbsp;some of my other work&nbsp;<a href="https://benzinga.com/cannabis" rel="nofollow noopener noreferrer" target="_blank">here</a>.&nbsp;
This article was originally published on <a href="https://www.forbes.com/sites/javierhasse/2024/05/01/i-chose-weed-over-drugs-tiffany-haddish-calls-for-cannabis-legalization-for-womens-health-talks-berner-collab/">Forbes </a>and appears here with permission.&nbsp;The article is from an external source. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.
Lead image courtesy of &quot;The Freak Brothers.&quot;

Cannabis

Health Care

Markets

Interview

General

Tiffany Haddish: 'If Men Had Period Pain, Weed Would Already Be Legal'

Adagio Medical Holdings Shares Halted On Circuit Breaker To The Downside, Stock Now Up 136.1%

Janover Shares Halted On A Circuit Breaker To The Downside; Stock Now Down -34.6%

TLRY

Tilray Brands shares are trading lower after the company announced it will vote to implement a reverse stock split, potentially upwards of a 1-to-20 basis.

Comments

Lufax Holding

Noticias

Últimas noticias sobre Lufax Holding (NYSE:LU) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL